Kevin Thornal
About Kevin Thornal
Kevin Thornal is the CEO and President of Nevro and a Board Member, having held the position since 2023. He has over 20 years of senior management experience, including significant roles at Hologic, Inc. and Stryker.
Current Role at Nevro
Kevin Thornal serves as the CEO and President of Nevro, a position he has held since 2023. He also holds a board member role within the organization. His leadership is based in Redwood City, California, where he oversees the company's strategic direction and operational management.
Previous Experience at Hologic, Inc.
Thornal has an extensive background at Hologic, Inc., where he worked for nearly nine years in various leadership roles. He served as the Group President of Global Diagnostic Solutions from 2022 to 2023, and prior to that, he held the position of President of Diagnostic Solutions from 2019 to 2022. His tenure also included roles as VP EMEA for Breast & Skeletal Health and Division President for Medical Aesthetics.
Career at Stryker
Thornal held multiple positions at Stryker from 2004 to 2014, gaining experience in sales, marketing, and business development. His roles included Sales Representative, Marketing/Brand Manager, Group Marketing Manager, and Director of Sales for Interventional Spine. This diverse experience contributed to his senior management skills.
Educational Background
Kevin Thornal earned a Bachelor of Arts degree in History from Southern Methodist University, where he also minored in English and Secondary Education. His education spanned from 1992 to 1996, providing a foundation for his future career in management and leadership.
Achievements in Molecular Diagnostics
During his time at Hologic, Thornal led the launch of three molecular diagnostic COVID-19 tests, contributing to the company's response to the pandemic. This initiative highlights his ability to manage critical projects in high-pressure environments.